Tag Archives: Allergan Inc. (AGN)

Latest Strategy in Valeant Pharmaceuticals Intl Inc (VRX) -Pershing- Allergan Inc (AGN) Negotiation – Raising Bid Price

Latest Strategy in Valeant Pharmaceuticals Intl Inc (VRX) -Pershing- Allergan Inc (AGN) Negotiation – Raising Bid Price

What happens when the share price of a particular company jumps by $15? There is an increase in the overall value of the company and this happens to be the latest strategy employed by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Pershing to persuade Allergan Inc (NYSE:AGN) to give its nod to the merger. April, 2014,

Allergan Inc (AGN) Sets Date to Decide On Possible Valeant Pharmaceuticals Intl Inc (VRX) Take-Over

Having lost a court battle intended to stall the aggressive proceedings of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Allergan Inc (NYSE:AGN) finally released the date for special meeting of shareholders as being December 18th, 2014. This date is a fall-out of decision of legal law-suit that went against Allergan Inc (NYSE:AGN) and in favor of Valeant

Allergan, Inc. (AGN) vs. Valeant Pharmaceuticals Intl Inc (VRX): Losing Ground to Stop Shareholder Meeting

Allergan, Inc. (NYSE:AGN) lost a crucial court bid that could have allowed the company to stop a shareholder meeting planned by Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and William Ackman. Ackman joined hands with Valeant in April with a cash-and-stock bid of $54 billion. (You can see entire holdings of William Ackman). Allergan, Inc. (NYSE:AGN) approached

Top